
USD
+$0.00
(+0.00%
)At Close (As of Dec 12, 2025)
$1.35B
Market Cap
-
P/E Ratio
-1.77
EPS
$8.70
52 Week High
$1.77
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Total Assets | $871M |
| Total Current Assets | $809M |
| Cash And Cash Equivalents At Carrying Value | $124M |
| Cash And Short Term Investments | $124M |
| Inventory | - |
| Current Net Receivables | - |
| Total Non Current Assets | $62M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $2.3M |
| Intangible Assets Excluding Goodwill | $2.3M |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $657M |
| Other Current Assets | $28M |
| Other Non Current Assets | - |
| Total Liabilities | $94M |
| Total Current Liabilities | $51M |
| Current Accounts Payable | $14M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $5.7M |
| Total Non Current Liabilities | $43M |
| Capital Lease Obligations | $49M |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $49M |
| Other Current Liabilities | $23M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $778M |
| Treasury Stock | - |
| Retained Earnings | -$1.7B |
| Common Stock | $168K |
| Common Stock Shares Outstanding | $143M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Relay Therapeutics, Inc. is a clinical-stage precision medicine company based in Cambridge, Massachusetts, focused on transforming drug discovery through its innovative protein motion platform. The company specializes in targeting allosteric sites to develop novel therapeutics for patients with specific genetic mutations, particularly in oncology and other areas with significant unmet medical needs. With a robust pipeline supported by strategic collaborations, Relay Therapeutics aims to advance treatment precision and improve patient outcomes, positioning itself as a leader in the evolving landscape of personalized medicine.